9:22 AM
Leo Group India
| ||
| NHF signs 43 pharmaceutical contracts Jamaica Observer FORTY-THREE contracts valued at more than $3 billion were Thursday signed between the Ministry of Health and suppliers of pharmaceuticals at the Jamaica Conference Centre in downtown Kingston. The contracts, which will run for 24 months, cover 769 ... See all stories on this topic » | ||
| Peregrine Pharmaceuticals Drug Extends Lives of Cancer Patients Minyanville.com MINYANVILLE ORIGINAL Lung cancer patients taking Peregrine Pharmaceuticals' (PPHM) experimental drug bavituximab in a company study lived twice as many months as those treated with only chemotherapy. The study results support Peregrine's plans ... See all stories on this topic » | ||
| 19000 kids use rejected 'unsafe' ADHD drug Concerta Herald Sun A subsidy for the medicine Concerta, a long acting form of ritalin, was recently knocked back for adults by the government's expert Pharmaceutical Benefits Advisory Committee "on the basis of uncertain efficacy and safety in the proposed PBS ... See all stories on this topic » | ||
| Peregrine Study Shows Bavituximab Boosts Lung-Cancer Survival Wall Street Journal Peregrine Pharmaceuticals Inc. (PPHM) said interim results from a Phase II trial showed the combined use of its bavituximab drug candidate with chemotherapy drug docetaxel had a statistically significant improvement in the overall survival rate for ... See all stories on this topic » | ||
| Pharmexcil to hold iPHEX 2013, in Mumbai from April 24 to 26, 2013 pharmabiz.com The Pharmaceuticals Export Promotion Council of India (Pharmexcil) will organise the iPHEX 2013--the mega exhibition of Indian pharmaceutical products and technologies-- in Mumbai from April 24 to 26, 2013. Over 400 international buyers including ... See all stories on this topic » | ||
| Best of the Blogs, Biotechnology: Valeant Makes Entrée Into Dermatology by ... Minyanville.com "The deal aims to make Valeant a major player in dermatological pharmaceuticals, both for the treatment of acne and in the market for aesthetic skin care, where it would go up against Botox, which is used to smooth wrinkles, Valeant Chief Executive ... See all stories on this topic » | ||
| TEXT-S&P assigns Valeant term loan 'BBB-' rating Reuters Sept 7 - Standard & Poor's Ratings Services said today that it assigned its 'BBB-' issue-level rating and '1' recovery rating to Montreal-based pharmaceutical company Valeant Pharmaceuticals International Inc.'s proposed $1 billion term loan B due 2019. See all stories on this topic » | ||
| ||
| State's drug bill could fall by up to €400m under new deal Irish Times The deal with the Irish Pharmaceutical Healthcare Association is expected to yield savings of €30 million to €40 million for the remaining months of this year, less than the projected €60 million to €70 million forecast by the Minister, according to ... See all stories on this topic » | ||
| Is Sanofi The Best Pharma Stock To Buy? Seeking Alpha The backbone of the value of a pharmaceutical company, i.e. its product pipeline, looks rich for Sanofi, and its top line has strengthened partly due to its recent acquisitions. The stock is relatively undervalued in the market, which leads us to ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment